• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Voluntis launches upgraded digital insulin dosing therapeutic

August 17, 2018 By Sarah Faulkner

Voluntis InsuliaVoluntis this week launched an upgraded version of Insulia, its digital therapeutic designed to give automated basal insulin dose recommendations and coaching messages for people with Type 2 diabetes.

The company touted that its upgraded version of Insulia improves user experience and offers Spanish programming.

“Over the past year, we’ve worked closely with the medical community and people with diabetes using Insulia to understand how we can further help meet their needs,” Ellie Strock, VP of U.S. medical affairs, said in prepared remarks. “The beauty of digital therapeutics like Insulia is that we can use this feedback to continuously improve them, making insulin management ever easier.”

Voluntis’ Insulia includes a web portal for healthcare practitioners to set up personalized treatment plans for their patients. Users receive a personalized app that uses blood glucose readings and symptoms of hypoglycemia to recommend insulin doses in real-time, according to Voluntis. User data is automatically shared with a healthcare team, who remotely monitor the user’s progress.

The Insulia program is compatible with Lantus, Levemir, Toujeo, Tresiba (U-100) and Basaglar basal insulins.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, Pharmaceuticals, Wall Street Beat Tagged With: Voluntis

IN CASE YOU MISSED IT

  • Dexcom updates CGM receiver recall that led to serious adverse events
  • Abbott reports momentum with Libre CGM business as new dual sensor will ‘accelerate’ growth
  • Johnson & Johnson wins FDA priority review for drug delivery system
  • Glucose monitoring company LifeScan files chapter 11 to reduce debt
  • Medtronic enrolls first patient in study for Onyx liquid embolic system

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS